The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
Abstract
Purpose: Data mining on electronic health records (EHRs) has emerged as a promising complementary method for post‐marketing drug safety surveillance. The EU‐ADR project, funded by the European Commission, is developing techniques that allow mining of EHRs for adverse drug events across different countries in Europe. Since mining on all possible events was considered to unduly increase the number of spurious signals, we wanted to create a ranked list of high‐priority events. Methods: Scientific literature, medical textbooks, and websites of regulatory agencies were reviewed to create a preliminary list of events that are deemed important in pharmacovigilance. Two teams of pharmacovigilance experts independently rated each event on five criteria: ‘trigger for drug withdrawal’, ‘trigger for black box warning’, ‘leading to emergency department visit or hospital admission’, ‘probability of event to be drug‐related’, and ‘likelihood of death’. In case of disagreement, a consensus score was obtained. Ordinal scales between 0 and 3 were used for rating the criteria, and an overall score was computed to rank the events. Results: An initial list comprising 23 adverse events was identified. After rating all the events and calculation of overall scores, a ranked list was established. The top‐ranking events were: cutaneous bullous eruptions, acute renal failure, anaphylactic shock, acute myocardial infarction, and rhabdomyolysis. Conclusions: A ranked list of 23 adverse drug events judged as important in pharmacovigilance was created to permit focused data mining. The list will need to be updated periodically as knowledge on drug safety evolves and new issues in drug safety arise. Copyright © 2009 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Systematic Review: Agranulocytosis Induced by Nonchemotherapy Drugs
Andersohn, F., Konzen, C., & Garbe, E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00009 · Cited by 479
Wysowski, D. K., & Swartz, L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1363 · Cited by 471
Cited by
Harpaz, R., DuMouchel, W., LePendu, P., Bauer-Mehren, A., Ryan, P., & Shah, N. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.24 · Cited by 333
A Systematic Review on Healthcare Analytics: Application and Theoretical Perspective of Data Mining
Islam, M. S., Hasan, M. M., Wang, X., Germack, H. D., & Noor-E-Alam, M. (2018) · Healthcare · doi:10.3390/healthcare6020054 · Cited by 267
Coloma, P. M., Schuemie, M. J., Trifirò, G., Gini, R., Herings, R., Hippisley‐Cox, J., Mazzaglia, G., Giaquinto, C., Corrao, G., Pedersen, L., et al. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2053 · Cited by 259
Self-citation
Metadata
- Authors
- Trifirò, G., Pariente, A., Coloma, P. M., Kors, J. A., Polimeni, G., Miremont‐Salamé, G., Catania, M. A., Salvo, F., David, A., Moore, N., Caputi, A. P., Sturkenboom, M., Molokhia, M., Hippisley‐Cox, J., Acedo, C. D., van der Lei, J., & Fourrier‐Reglat, A.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2009-09-15
- Volume
- 18
- Issue
- 12
- Pages
- 1176-1184
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W1989986729
- Cited by
- 183
- References
- 4
- FWCI
- 19.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.